Direct Radiolabeling of Trastuzumab-Targeting Triblock Copolymer Vesicles with 89Zr for Positron Emission Tomography Imaging
- 16 March 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 24 (4) , 1784-1797
Abstract
Radiolabeled drug nanocarriers that can be easily imaged via positron emission tomography (PET) are highly significant as their in vivo outcome can be quantitatively PET-traced with high sensitivity. However, typical radiolabeling of most PET-guided theranostic vehicles utilizes modification with chelator ligands, which presents various challenges. In addition, unlike passive tumor targeting, specific targeting of drug delivery vehicles via binding affinity to overexpressed cancer cell receptors is crucial to improve the theranostic delivery to tumors. Herein, we developed( 89)Zr-labeled triblock copolymer polymersomes of 60 nm size through chelator-free radiolabeling. The polymersomes are assembled from poly(N-vinyl-pyrrolidone)(5)-b-poly(dimethylsiloxane)(30)-b-poly(N-vinylpyrrolidone)(5) (PVPON5-PDMS30-PVPON5) triblock copolymers followed by adsorption of a degradable tannin, tannic acid (TA), on the polymersome surface through hydrogen bonding. TA serves as an anchoring layer for both Zr-89 radionuclide and targeting recombinant humanized monoclonal antibody, trastuzumab (Tmab). Unlike bare PVPON5-PDMS30-PVPON5 polymersomes, TA -and Tmab-modified polymersomes demonstrated a high radiochemical yield of more than 95%. Excellent retention of Zr-89 by the vesicle membrane for up to 7 days was confirmed by PET in vivo imaging. Animal biodistribution using healthy BALB/c mice confirmed the clearance of Zr-89-labeled polymersomes through the spleen and liver without their accumulation in bone, unlike the free nonbound Zr-89 radiotracer. The Zr-89-radiolabeled polymersomes were found to specifically target BT474 HER2-positive breast cancer cells via the Tmab-TA complex on the vesicle surface. The noncovalent Tmab anchoring to the polymersome membrane can be highly advantageous for nanoparticle modification compared to currently developed covalent methods, as it allows easy and quick integration of a broad range of targeting proteins. Given the ability of these polymersomes to encapsulate and release anticancer therapeutics, they can be further expanded as precision-targeted therapeutic carriers for advancing human health through highly effective drug delivery strategies.Keywords
Funding Information
- Division of Materials Research (2208831)
- Department of Radiology, University of Alabama at Birmingham
This publication has 87 references indexed in Scilit:
- Effect of pH and Temperature on PMPC–PDPA Copolymer Self-AssemblyMacromolecules, 2013
- Enhancing the Effects of Low Dose Doxorubicin Treatment by the Radiation in T47D and SKBR3 Breast Cancer CellsJournal of Breast Cancer, 2013
- Rapid Size-Controlled Synthesis of Dextran-Coated, 64Cu-Doped Iron Oxide NanoparticlesACS Nano, 2012
- In vivo biodistribution and accumulation of 89Zr in miceNuclear Medicine and Biology, 2011
- pH-induced metal-ligand cross-links inspired by mussel yield self-healing polymer networks with near-covalent elastic moduliProceedings of the National Academy of Sciences of the United States of America, 2011
- 2DG enhances the susceptibility of breast cancer cells to doxorubicinOpen Life Sciences, 2010
- Protein Binding and Astringent Taste of a Polymeric Procyanidin, 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranose, Castalagin, and GrandininJournal of Agricultural and Food Chemistry, 2006
- CNS Malignancies: At Last, Real ProgressJournal of Clinical Oncology, 2006
- Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabNature, 2003
- Synthesis and characterization of α,ω‐bis(4‐hydroxybutyl) polydimethylsiloxanesJournal of Polymer Science Part A: Polymer Chemistry, 1995